Indomethacin for treatment of prolapsed amniotic sac “hourglass membranes” presented at late mid-trimester

References

1. ↵
   1. Beck S,
   2. Wojdyla D,
   3. Say L,
   4. Betran AP,
   5. Merialdi M,
   6. Requejo JH,
   7. et al.

   (2010) The worldwide incidence of preterm birth: a systematic review of maternal mortality and morbidity. Bull World Health Organ 88:31–38.

   OpenUrlCrossRefPubMedWeb of Science
2. ↵
   1. Namouz S,
   2. Porat S,
   3. Okun N,
   4. Windrim R,
   5. Farine D

   (2013) Emergency cerclage: literature review. Obstet Gynecol Surv 68:379–388.

   OpenUrl
3. ↵
   1. Miller ES,
   2. Grobman WA,
   3. Fonseca L,
   4. Robinson BK

   (2014) Indomethacin and Antibiotics in Examination-Indicated Cerclage: A Randomized Controlled Trial. Obstet Gynecol 124:637.

   OpenUrl
4. ↵
   1. Sharma R,
   2. Hudak ML,
   3. Tepas JJ,
   4. Wludyka PS,
   5. Teng RJ,
   6. Hastings LK,
   7. et al.

   (2010) Prenatal or postnatal indomethacin exposure and neonatal gut injury associated with isolated intestinal perforation and necrotizing enterocolitis. J Perinatol 30:786–793.

   OpenUrlCrossRefPubMedWeb of Science
5. ↵
   1. Vogel M,
   2. Wilkins-Haug LE,
   3. McElhinney DB,
   4. Marshall AC,
   5. Benson CB,
   6. Silva V,
   7. et al.

   (2010) Reversible ductus arteriosus constriction due to maternal indomethacin after fetal intervention for hypoplastic left heart syndrome with intact/restrictive atrial septum. Fetal Diagn Ther 27:40–45.

   OpenUrlCrossRefPubMed
6. ↵
   1. Abou-Ghannam G,
   2. Usta IM,
   3. Nassar AH

   (2012) Indomethacin in pregnancy: applications and safety. Am J Perinatol 29:175–186.

   OpenUrlPubMed